Overview

Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study

Status:
Recruiting
Trial end date:
2028-01-15
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine if a combination of oral nicotinamide and pyruvate (N&P) can maintain eye health as compared to placebo while standard-of-care intraocular pressure-lowering glaucoma medications are used to treat glaucoma.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Columbia University
Treatments:
Niacin
Niacinamide
Nicotinic Acids